Clinical Trials List
2020-09-22 - 2024-03-29
Phase III
Terminated7
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 柯皓文 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 邱立忠 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 林定佑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yu-Min Yeh Division of General Internal Medicine
- Yi-Ting Yen Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
- Po-Lan Su Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Xin-Min Liao Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Yau-Lin Tseng Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Hsin-Yu Liu Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- 魏以宣 Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 趙東瀛 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 陳泓丞 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- CHIN-CHOU WANG Division of Thoracic Medicine
- 張育平 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chi-Lu Chiang Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-Hsiang Li Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- 廖偉志 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
393 participants
